methotrexate

Key facts

INN

methotrexate

Brand

METHOTREXATE

Route

ORAL

Formulation

SOLUTION

Related patents

patent

US 12246064

Method of treating Crohn's disease by administering a triple combination therapy

Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12005061

Ophthalmic formulations of methotrexate

Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12005060

Ophthalmic formulations of methotrexate

Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11911385

Methotrexate treatment methods

Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11253604

Conjugate of methotrexate and peptide

Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10028911

Sustained release formulation of methotrexate as a disease-modifying antirheumat

Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9770414

Sustained release formulation of methotrexate as a disease-modifying antirheumat

Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 8865728

Combinations comprising methotrexate and DHODH inhibitors

Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is methotrexate?

methotrexate (METHOTREXATE), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for methotrexate?

METHOTREXATE is a marketed brand name for methotrexate. Check FDA Drugs@FDA for the current US label holder.